Canton Hathaway’s Bristol-Myers Squibb BMY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$61K	Buy	1,320 +50	+4%	+$2.31K	0.01%	186
2025 Q1	$77K	Buy	1,270 +275	+28%	+$16.7K	0.02%	175
2024 Q4	$56K	Buy	995 +300	+43%	+$16.9K	0.01%	155
2024 Q3	$36K	Hold	695	–	–	0.01%	187
2024 Q2	$29K	Hold	695	–	–	0.01%	202
2024 Q1	$38K	Hold	695	–	–	0.01%	176
2023 Q4	$36K	Hold	695	–	–	0.01%	181
2023 Q3	$40K	Hold	695	–	–	0.01%	167
2023 Q2	$44K	Hold	695	–	–	0.01%	166
2023 Q1	$48K	Hold	695	–	–	0.02%	157
2022 Q4	$50K	Hold	695	–	–	0.02%	162
2022 Q3	$49K	Sell	695 -500	-42%	-$35.3K	0.02%	153
2022 Q2	$92K	Hold	1,195	–	–	0.03%	127
2022 Q1	$87K	Hold	1,195	–	–	0.02%	136
2021 Q4	$75K	Sell	1,195 -25,343	-95%	-$1.59M	0.02%	157
2021 Q3	$1.57M	Sell	26,538 -4,505	-15%	-$267K	0.45%	43
2021 Q2	$2.07M	Sell	31,043 -839	-3%	-$56.1K	0.61%	33
2021 Q1	$2.01M	Buy	31,882 +6,582	+26%	+$416K	0.64%	29
2020 Q4	$1.57M	Buy	25,300 +9,110	+56%	+$565K	0.53%	37
2020 Q3	$976K	Buy	16,190 +10,290	+174%	+$620K	0.4%	36
2020 Q2	$347K	Sell	5,900 -940	-14%	-$55.3K	0.23%	52
2020 Q1	$381K	Buy	6,840 +940	+16%	+$52.4K	0.27%	40
2019 Q4	$379K	Sell	5,900 -870	-13%	-$55.9K	0.19%	61
2019 Q3	$343K	Buy	6,770 +6,270	+1,254%	+$318K	0.19%	61
2019 Q2	$23K	Hold	500	–	–	0.01%	171
2019 Q1	$23K	Hold	500	–	–	0.01%	170
2018 Q4	$26K	Hold	500	–	–	0.02%	130
2018 Q3	$31K	Buy	+500	New	+$31K	0.02%	117